Stomach Cancer Awareness Month

United States, Canada, United Kingdom, Australia, Ireland, India, Japan

About

Stomach Cancer Awareness Month is observed throughout November to raise awareness of stomach cancer, its potential risk factors, and the importance of recognizing concerning symptoms. The month encourages people to learn more about the disease, ask questions about their health, and speak with a healthcare professional about any persistent or unusual changes.

Throughout November, communities come together to share reliable information, support patients and families, and honor those affected by stomach cancer. It is also an opportunity to promote compassion, encourage informed conversations, and support research and care efforts that can lead to earlier detection and better outcomes.

History

Stomach Cancer Awareness Month is observed throughout November to raise public understanding of stomach, or gastric, cancer. The observance developed from broader efforts by cancer organizations, medical professionals, researchers, patients, and families to bring greater attention to a disease that has historically received less public visibility than several other major cancers. Awareness campaigns commonly focus on risk factors, symptoms, diagnosis, treatment, and the importance of discussing persistent digestive problems with a health-care professional.

The history of the observance reflects the changing understanding of stomach cancer itself. For much of the 20th century, many cases were identified only after the disease had advanced, when symptoms could be difficult to distinguish from common stomach ailments. Improvements in endoscopy, imaging, pathology, surgery, chemotherapy, targeted medicines, and immunotherapy have gradually expanded the ability to detect and treat gastric cancers. Awareness initiatives have evolved alongside these advances, emphasizing that symptoms such as ongoing indigestion, unexplained weight loss, abdominal discomfort, vomiting, difficulty swallowing, or feeling full unusually quickly should not be ignored.

Over time, Stomach Cancer Awareness Month has also become a platform for sharing the experiences of survivors and bereaved families. Personal stories help explain the varied effects of the disease and encourage people to seek medical advice rather than dismissing persistent symptoms. Campaigns also highlight factors associated with increased risk, including *Helicobacter pylori* infection, smoking, certain inherited conditions, family history, and diets high in heavily preserved foods, while recognizing that stomach cancer can occur in people without obvious risk factors.

Culturally, the month contributes to a broader effort to reduce silence around gastrointestinal cancers and to promote more equitable attention to diseases that may be less familiar to the public. It supports conversations about prevention, early evaluation, clinical trials, and access to specialized care, while honoring those affected by stomach cancer. Although the observance does not have one universally documented founding event, its continuing history is rooted in coordinated education and advocacy intended to improve recognition, research, treatment, and support for people affected by gastric cancer.

Timeline

1881
Theodor Billroth performed the first successful partial gastrectomy for gastric cancer, a landmark in surgical treatment of stomach cancer.
1982
Barry Marshall and Robin Warren identified spiral bacteria, later named Helicobacter pylori, in the stomachs of patients with gastritis and peptic ulcer disease, beginning work that transformed understanding of stomach-cancer risk.
1994
The International Agency for Research on Cancer classified Helicobacter pylori as a Group 1 carcinogen, recognizing its causal role in human gastric cancer.
2005
Barry J. Marshall and J. Robin Warren received the Nobel Prize in Physiology or Medicine for discovering Helicobacter pylori and its role in gastritis and peptic ulcer disease; the discovery also established a major preventable cause of stomach cancer.
2014
The Cancer Genome Atlas Research Network published a molecular characterization of gastric adenocarcinoma, defining four major genomic subtypes of this stomach cancer.

Upcoming dates

Sources

Same day

Related